116 related articles for article (PubMed ID: 11180767)
1. 5'-deoxy-5-fluorouridine, medroxyprogestrone acetate and mitoxantrone hydrochloride for advanced or recurrent breast cancer.
Sato K; Hiraide H; Tamakuma S; Tabei T; Maruyama M; Touma M; Okamura H; Matsumoto F; Akao S; Ishikawa H; Yagi Y; Mochizuki H
Breast Cancer; 2001; 8(1):58-62. PubMed ID: 11180767
[TBL] [Abstract][Full Text] [Related]
2. A phase II trial of mitomycin C, 5'-deoxy-5-fluorouridine, etoposide and medroxyprogesterone acetate (McVD-MPA) as a salvage chemotherapy to anthracycline-resistant tumor in relapsed breast cancer and its mechanism(s) of antitumor action.
Kim R; Osaki A; Tanabe K; Kojima J; Toge T
Oncol Rep; 2001; 8(3):597-603. PubMed ID: 11295087
[TBL] [Abstract][Full Text] [Related]
3. A combination chemoendocrine therapy of mitoxantrone, doxifluridine, and medroxyprogesterone acetate for anthracycline-resistant advanced breast cancer.
Iino Y; Yokoe T; Sugamata N; Maemura M; Takei H; Horiguchi J; Takeyoshi I; Ohwada S; Morishita Y; Kusaba T; Ishida T; Yokomori T; Fujii T; Endo K; Shiozaki H; Aiba S; Takano A; Kishi S
Cancer Chemother Pharmacol; 1998; 41(3):243-7. PubMed ID: 9443642
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of mitoxantrone, doxifluridine and medroxyprogesterone acetate as second-line treatment for anthracycline-resistant metastatic breast cancer.
Yokoe T; Iino Y; Sugamata N; Aoyagi H; Takai Y; Takei H; Maemura M; Ohwada S; Morishita Y
Anticancer Res; 1995; 15(5B):2303-5. PubMed ID: 8572643
[TBL] [Abstract][Full Text] [Related]
5. [A case of breast cancer with liver metastases responding remarkably to combination therapy of mitoxantrone (MIT), doxifluridine (5'-DFUR) and medroxyprogesterone acetate (MPA)].
Fujitake S; Maeda Y; Shimizu M; Nozaki H; Tohyama M; Kataoka S
Gan To Kagaku Ryoho; 1999 Jul; 26(8):1177-80. PubMed ID: 10431585
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy with mitoxantrone for the treatment of recurrent breast cancer].
Matsuoka T; Nomizu T; Yabuta T; Katagata N; Watanabe F; Yamaki Y; Tsuchiya A; Takenoshita S
Gan To Kagaku Ryoho; 2000 Jul; 27(7):1051-5. PubMed ID: 10925694
[TBL] [Abstract][Full Text] [Related]
7. [A case of recurrent breast cancer responding to combination therapy with mitoxantrone (MIT), 5'-deoxy-5-fluorouridine (5'-DFUR) and medroxyprogesterone acetate (MPA)].
Kobayashi J; Kubota K; Ishikawa H; Asaumi S; Iwanami K; Matsumoto H; Kawashima K; Yokoe T; Iino Y; Morishita Y
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2513-6. PubMed ID: 7944501
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of long-term oral chemotherapy with 5'-deoxy-5-fluorouridine and cyclophosphamide for recurrent breast cancer.
Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
Int J Clin Oncol; 2004 Oct; 9(5):383-7. PubMed ID: 15549589
[TBL] [Abstract][Full Text] [Related]
9. [Advanced breast cancer with remarkable response to the combination therapy of mitoxantrone (MIT) and medroxyprogesteron acetate (MPA) after failure of anthracycline therapy: a case report].
Izumi M; Iino Y; Yokoe T; Inoue T; Yamada T; Kobayashi I; Andoh T; Yokota T; Iijima T; Morishita Y
Gan To Kagaku Ryoho; 1994 Feb; 21(2):265-8. PubMed ID: 8311500
[TBL] [Abstract][Full Text] [Related]
10. [Usefulness of low dose 5'-DFUR (5'-deoxy-5-fluorouridine) for advanced or recurrent breast cancer].
Sonoo H; Senoo T; Nishiki M; Morimoto T; Takashima S
Gan To Kagaku Ryoho; 1999 Jun; 26(7):951-8. PubMed ID: 10396323
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of oral combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR) and cyclophosphamide for metastatic breast cancer.
Yamashita T; Yamashita H; Itoh Y; Karamatsu S; Itoh K; Hara Y; Ando Y; Sugiura H; Kuzushima T; Toyama T; Iwata H; Kobayashi S; Iwase H
Breast Cancer; 2006; 13(4):334-9. PubMed ID: 17146158
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of weekly paclitaxel and doxifluridine (5'-DFUR) combination therapy in patients with advanced or recurrent breast cancer].
Okamoto Y; Tominaga T; Okuyama N; Sawada T; Kou Y
Gan To Kagaku Ryoho; 2003 May; 30(5):661-7. PubMed ID: 12795098
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of safety and efficacy for bi-weekly Docetaxel and 5'-DFUR combination therapy in patients with advanced or recurrent breast cancer--Phase I study].
; Ikeda M; Sonoo H; Tanaka K; Kurebayashi J; Morimoto T; Tangoku A; Komaki K; Kataoka T; Ishiguro K; Yoshizawa K
Gan To Kagaku Ryoho; 2006 Jun; 33(6):767-71. PubMed ID: 16770094
[TBL] [Abstract][Full Text] [Related]
14. [The efficacy of combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR), cyclophosphamide (CPA) and medroxyprogesterone acetate (MPA) for bone metastasis in breast cancer patients].
Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
Gan To Kagaku Ryoho; 2001 Jul; 28(7):973-7. PubMed ID: 11478147
[TBL] [Abstract][Full Text] [Related]
15. [Successful treatment of advanced recurent breast cancer using DMpC therapy as maintenance therapy].
Miyamoto H; Yoshida S; Imatomi M; Saitoh T; Nakata A
Gan To Kagaku Ryoho; 2002 Mar; 29(3):427-9. PubMed ID: 11915733
[TBL] [Abstract][Full Text] [Related]
16. [The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient].
Toi M; Taniguchi T; Hayashi K; Tominaga T
Gan To Kagaku Ryoho; 1995 May; 22(6):799-804. PubMed ID: 7755388
[TBL] [Abstract][Full Text] [Related]
17. [A phase I study of docetaxel (TXT) and doxifluridine (5'-DFUR) combination therapy in patients with advanced and recurrent breast cancer].
Tominaga T; Nishimura R; Aoyama H; Iwase H; Mitsuyama S; Asaga T; Kimura M;
Gan To Kagaku Ryoho; 2001 Jul; 28(7):965-72. PubMed ID: 11478146
[TBL] [Abstract][Full Text] [Related]
18. [5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer].
Yoshinaka K; Yagi M; Ohtagaki S; Toi M; Toge T
Gan To Kagaku Ryoho; 1991 Jan; 18(1):115-8. PubMed ID: 1824814
[TBL] [Abstract][Full Text] [Related]
19. [Successful treatment of disseminated breast cancer with combination therapy of 5'-deoxy-5'-fluorouridine (5'-DFUR), medroxyprogesterone acetate (MPA) and cyclophosphamide (CPA)].
Takatsuka Y; Katoh T; Tsumura I; Kobayakawa K; Kawahara T
Gan To Kagaku Ryoho; 1992 Jan; 19(1):107-10. PubMed ID: 1530905
[TBL] [Abstract][Full Text] [Related]
20. Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer patients. A phase II study.
Perrone F; De Placido S; Carlomagno C; Gravina A; De Laurentiis M; Del Mastro L; Gridelli C; Pagliarulo C; Bianco AR
Am J Clin Oncol; 1994 Jun; 17(3):218-22. PubMed ID: 8192105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
